Lack of p53 function has been found to be advantageous for tumor cells by downregulating hypoxia-induced apoptosis [24–27] and interfering with ETC assembly and promoting a shift in metabolism to a more glycolytic state [28]. This evidence concerns the gene TP53 and neoplasm.